U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288320) titled 'An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania' on Dec. 15.

Brief Summary: The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an episode of mania with or without mixed features.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Bipolar I Disorder Mania

Intervention: DRUG: NBI-1117568

Oral administration

DRUG: Placebo

Oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Neur...